Zimbabwe faces LCIA claim over covid-19 testing kits

Zimbabwe’s state-owned pharmaceutical company has been threatened with an LCIA claim over the termination of a US$60 million contract to supply covid-19 testing kits, amid a criminal investigation that has led to charges against the country’s former health minister.


Get unlimited access to all Global Arbitration Review content